Sexually-Transmitted Infections (STIs)Pelvic Inflammatory Disease(PID)Panel

Sexually-Transmitted Infections (STIs)Pelvic Inflammatory Disease(PID)Panel

Test Code

36965
87494, 87661, 87563
CPT coding may differ dependent on payer rules which may impact prior authorization testing.
Please direct any questions regarding CPT coding to the payer being billed.
36965
87494, 87661, 87563
CPT coding may differ dependent on payer rules which may impact prior authorization testing.
Please direct any questions regarding CPT coding to the payer being billed.
In-home collection is not available in your area through Quest Mobile.

Clinical Significance

Sexually-Transmitted Infections (STIs)Pelvic Inflammatory Disease(PID)Panel - Pelvic inflammatory disease (PID) is an infection of the female reproductive organs and often due to sexually transmitted infections. It may be caused by Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and/or Mycoplasma genitalium. Most women are asymptomatic. For those that present with symptoms, the symptoms may include pain in the lower abdomen and pelvis, heavy vaginal discharge with an unpleasant odor, abnormal vaginal bleeding, and pain during intercourse. A panel will help the clinician identify the cause of these symptoms.

Test Details

Includes

  • Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
    Trichomonas vaginalis RNA, Qualitative, TMA
    Mycoplasma genitalium, rRNA, TMA

Patient Preparation

Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen.

Methodology

Transcription-Mediated Amplification (TMA)

Reference Range(s)

Chlamydia trachomatis RNA, TMA, UrogenitalNot detected
Neisseria gonorrhoeae RNA, TMA, UrogenitalNot detected
Trichomonas vaginalis RNA, QL, TMANot detected
Mycoplasma genitalium, rRNA, TMANot detected

Alternative Name(s)

Trichomoniasis,Vaginitis,CT/GC APTIMA®,Urine Trichomonas,CT/NG APTIMA®,CT/NG TMA,STI Pelvic Inflammatory Disease (PID) Panel,PID,Mycoplasma genitalium TMA,Hologic

LOINC® Codes, Performing Laboratory

Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
Trichomonas vaginalis RNA, Qualitative, TMA
Mycoplasma genitalium, rRNA, TMA
Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen.

Methodology

Transcription-Mediated Amplification (TMA)

Reference Range(s)

Chlamydia trachomatis RNA, TMA, UrogenitalNot detected
Neisseria gonorrhoeae RNA, TMA, UrogenitalNot detected
Trichomonas vaginalis RNA, QL, TMANot detected
Mycoplasma genitalium, rRNA, TMANot detected

Alternative Name(s)

Trichomoniasis,Vaginitis,CT/GC APTIMA®,Urine Trichomonas,CT/NG APTIMA®,CT/NG TMA,STI Pelvic Inflammatory Disease (PID) Panel,PID,Mycoplasma genitalium TMA,Hologic

Preferred Specimen(s)

Vaginal or endocervical swab collected in an Aptima® transport tube or
2 mL urine collected in an Aptima® transport tube

Collection Instructions

Vaginal swab: Follow instructions in the Aptima® Multitest Swab Specimen Collection Kit (orange label). Age restrictions may apply. See individual tests for further information.

Endocervical swab: Follow instructions in the Aptima® Unisex Swab Specimen Collection Kit (white label). In females, to ensure collection of cells infected with N. gonorrhoeae/C. trachomatis, columnar epithelial cells lining the endocervix should be obtained. Excess mucus should be removed prior to sampling.

Female urine: Direct patient to provide first-catch urine (a maximum of 20-30 mL of the initial urine stream) into a urine collection cup free of any preservatives. 2 mL of urine specimen must be transferred into the Aptima® specimen transport tube within 24 hours of collection and before being assayed. Use tube provided in the urine specimen collection kit. The fluid (urine plus transport media) level in the urine tube must fall within the clear pane on the tube label.

Transport Container

See Collection Instructions

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 14 days
  • Refrigerated: 14 days
  • Frozen: 30 days

Reject Criteria

Transport tubes with 2 swabs • Transport tubes with Non-Aptima® swab • Swab transport tubes with no swab • Swab or urine submitted in Non-Aptima® transport tube • Urine samples where the fluid level is not between the black fill lines • Raw urine • ThinPrep® vial • Male urine • Patients less than 15 years of age

Setup Schedule

Vaginal or endocervical swab collected in an Aptima® transport tube or
2 mL urine collected in an Aptima® transport tube
Vaginal swab: Follow instructions in the Aptima® Multitest Swab Specimen Collection Kit (orange label). Age restrictions may apply. See individual tests for further information.

Endocervical swab: Follow instructions in the Aptima® Unisex Swab Specimen Collection Kit (white label). In females, to ensure collection of cells infected with N. gonorrhoeae/C. trachomatis, columnar epithelial cells lining the endocervix should be obtained. Excess mucus should be removed prior to sampling.

Female urine: Direct patient to provide first-catch urine (a maximum of 20-30 mL of the initial urine stream) into a urine collection cup free of any preservatives. 2 mL of urine specimen must be transferred into the Aptima® specimen transport tube within 24 hours of collection and before being assayed. Use tube provided in the urine specimen collection kit. The fluid (urine plus transport media) level in the urine tube must fall within the clear pane on the tube label.
See Collection Instructions
Room temperature
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days
Transport tubes with 2 swabs • Transport tubes with Non-Aptima® swab • Swab transport tubes with no swab • Swab or urine submitted in Non-Aptima® transport tube • Urine samples where the fluid level is not between the black fill lines • Raw urine • ThinPrep® vial • Male urine • Patients less than 15 years of age
In-home collection is not available in your area through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.